宋超（Mr. Song）
江苏先声诊断医学诊断有限公司执行总监，转化所所长助理
He is currently the Executive Director of Simcere Diagnostics and assistant to the Director of the Institute of Translational Medicine and Innovative Drug Technology.
他毕业于比利时鲁汶大学，主修生物化学。他得到了天津市“131”创新人才培养工程的资助，并在北京工作。在Novogene等国内知名公司担任中高级职务；先后负责数十项新产品和新技术的开发、项目产业化实施、国内外BD项目实施等，在项目管理和产品商业化方面具有丰富的经验。截至目前，已撰写发表SCI论文6篇，授权专利1项。2020年受聘为南京医科大学口腔医学院兼职教授，指导5名研究生完成联合培养工作，其中2名研究生受聘于公司，3名研究生继续攻读博士学位，使该公司成为分子诊断领域的领先公司。他带领公司通过了美国病理学家协会CAP实验室认证、美国病理学家学会质量评估、欧盟分子诊断质量联盟。
He graduated from the University of Leuven in Belgium with a major in biochemistry. He was supported by the Tianjin "131" innovative talent training project and worked in Beijing. Intermediate and senior positions in well-known domestic companies such as Novogene; successively responsible for the development of dozens of new products and technologies, project industrialization implementation, domestic and foreign BD project implementation, etc., with rich experience in project management and product commercialization. Up to now, 6 SCI papers have been written and published, and 1 patent has been authorized. In 2020, he was hired as a part-time professor of Nanjing Medical University School of Stomatology, guiding 5 postgraduates to complete the joint training work, of which 2 postgraduates were employed in the company, and 3 postgraduates continued to study for doctoral degrees. Song Chao, as the company's executive director, led the company to become a leading company in the field of molecular diagnostics. He led the company to pass the CAP laboratory certification of the American Association of Pathologists, the quality evaluation of the American Pathologists Association, and the EU Molecular Diagnostic Quality Alliance.
Telephone:+86 (0)512
Address:
Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
江苏先声诊断医学诊断有限公司执行总监，转化所所长助理
He is currently the Executive Director of Simcere Diagnostics and assistant to the Director of the Institute of Translational Medicine and Innovative Drug Technology.
他毕业于比利时鲁汶大学，主修生物化学。他得到了天津市“131”创新人才培养工程的资助，并在北京工作。在Novogene等国内知名公司担任中高级职务；先后负责数十项新产品和新技术的开发、项目产业化实施、国内外BD项目实施等，在项目管理和产品商业化方面具有丰富的经验。截至目前，已撰写发表SCI论文6篇，授权专利1项。2020年受聘为南京医科大学口腔医学院兼职教授，指导5名研究生完成联合培养工作，其中2名研究生受聘于公司，3名研究生继续攻读博士学位，使该公司成为分子诊断领域的领先公司。他带领公司通过了美国病理学家协会CAP实验室认证、美国病理学家学会质量评估、欧盟分子诊断质量联盟。
He graduated from the University of Leuven in Belgium with a major in biochemistry. He was supported by the Tianjin "131" innovative talent training project and worked in Beijing. Intermediate and senior positions in well-known domestic companies such as Novogene; successively responsible for the development of dozens of new products and technologies, project industrialization implementation, domestic and foreign BD project implementation, etc., with rich experience in project management and product commercialization. Up to now, 6 SCI papers have been written and published, and 1 patent has been authorized. In 2020, he was hired as a part-time professor of Nanjing Medical University School of Stomatology, guiding 5 postgraduates to complete the joint training work, of which 2 postgraduates were employed in the company, and 3 postgraduates continued to study for doctoral degrees. Song Chao, as the company's executive director, led the company to become a leading company in the field of molecular diagnostics. He led the company to pass the CAP laboratory certification of the American Association of Pathologists, the quality evaluation of the American Pathologists Association, and the EU Molecular Diagnostic Quality Alliance.
Contact information
Telephone:+86 (0)512
Address:Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
